Incidence and costs of hypoglycemia in insulin-treated diabetes in Switzerland : a health-economic analysis

Tzogiou, Christina; Wieser, Simon; Eichler, Klaus; Carlander, Maria; Djalali, Sima; Rosemann, Thomas; Brändle, Michael

doi:10.1016/j.jdiacomp.2023.108476

Please use this identifier to cite or link to this item: https://doi.org/10.21256/zhaw-28185

Publication type:	Article in scientific journal
Type of review:	Peer review (publication)
Title:	Incidence and costs of hypoglycemia in insulin-treated diabetes in Switzerland : a health-economic analysis
Authors:	Tzogiou, Christina Wieser, Simon Eichler, Klaus Carlander, Maria Djalali, Sima Rosemann, Thomas Brändle, Michael
et. al:	No
DOI:	10.1016/j.jdiacomp.2023.108476 10.21256/zhaw-28185
Published in:	Journal of Diabetes and its Complications
Volume(Issue):	37
Issue:	6
Page(s):	108476
Issue Date:	Jun-2023
Publisher / Ed. Institution:	Elsevier
ISSN:	1056-8727 1873-460X
Language:	English
Subjects:	Diabetes mellitus; Hypoglycemia; Insulin; Medical cost; Production loss; Switzerland
Subject (DDC):	362.1041: Health economics
Abstract:	Aims: We assess the incidence and economic burden of severe and non-severe hypoglycemia in insulin-treated diabetes type 1 and 2 patients in Switzerland. Methods: We developed a health economic model to assess the incidence of hypoglycemia, the subsequent medical costs, and the production losses in insulin-treated diabetes patients. The model distinguishes between severity of hypoglycemia, type of diabetes, and type of medical care. We used survey data, health statistics, and health care utilization data extracted from primary studies. Results: The number of hypoglycemic events in 2017 was estimated at 1.3 million in type 1 diabetes patients and at 0.7 million in insulin-treated type 2 diabetes patients. The subsequent medical costs amount to 38 million Swiss Francs (CHF), 61 % of which occur in type 2 diabetes. Outpatient visits dominate costs in both types of diabetes. Total production losses due to hypoglycemia amount to CHF 11 million. Almost 80 % of medical costs and 39 % of production losses are due to non-severe hypoglycemia. Conclusions: Hypoglycemia leads to substantial socio-economic burden in Switzerland. Greater attention to non-severe hypoglycemic events and to severe hypoglycemia in type 2 diabetes could have a major impact on reducing this burden.
URI:	https://digitalcollection.zhaw.ch/handle/11475/28185
Fulltext version:	Published version
License (according to publishing contract):	CC BY 4.0: Attribution 4.0 International
Departement:	School of Management and Law
Organisational Unit:	Winterthur Institute of Health Economics (WIG)
Appears in collections:	Publikationen School of Management and Law

Files in This Item:

File	Description	Size	Format
2023_Tzogiou-etal_Incidence-and-cost-of-hypoglycemia-insulin-treated-diabetes-CH.pdf		3.51 MB	Adobe PDF	View/Open

Show full item record

Tzogiou, C., Wieser, S., Eichler, K., Carlander, M., Djalali, S., Rosemann, T., & Brändle, M. (2023). Incidence and costs of hypoglycemia in insulin-treated diabetes in Switzerland : a health-economic analysis. Journal of Diabetes and Its Complications, 37(6), 108476. https://doi.org/10.1016/j.jdiacomp.2023.108476

Tzogiou, C. et al. (2023) ‘Incidence and costs of hypoglycemia in insulin-treated diabetes in Switzerland : a health-economic analysis’, Journal of Diabetes and its Complications, 37(6), p. 108476. Available at: https://doi.org/10.1016/j.jdiacomp.2023.108476.

C. Tzogiou et al., “Incidence and costs of hypoglycemia in insulin-treated diabetes in Switzerland : a health-economic analysis,” Journal of Diabetes and its Complications, vol. 37, no. 6, p. 108476, Jun. 2023, doi: 10.1016/j.jdiacomp.2023.108476.

TZOGIOU, Christina, Simon WIESER, Klaus EICHLER, Maria CARLANDER, Sima DJALALI, Thomas ROSEMANN und Michael BRÄNDLE, 2023. Incidence and costs of hypoglycemia in insulin-treated diabetes in Switzerland : a health-economic analysis. Journal of Diabetes and its Complications. Juni 2023. Bd. 37, Nr. 6, S. 108476. DOI 10.1016/j.jdiacomp.2023.108476

Tzogiou, Christina, Simon Wieser, Klaus Eichler, Maria Carlander, Sima Djalali, Thomas Rosemann, and Michael Brändle. 2023. “Incidence and Costs of Hypoglycemia in Insulin-Treated Diabetes in Switzerland : A Health-Economic Analysis.” Journal of Diabetes and Its Complications 37 (6): 108476. https://doi.org/10.1016/j.jdiacomp.2023.108476.

Tzogiou, Christina, et al. “Incidence and Costs of Hypoglycemia in Insulin-Treated Diabetes in Switzerland : A Health-Economic Analysis.” Journal of Diabetes and Its Complications, vol. 37, no. 6, June 2023, p. 108476, https://doi.org/10.1016/j.jdiacomp.2023.108476.